Financial News
Latest News about PFE
Recent news which mentions PFE
From MarketWatch
Booster Shots Might Not Be Enough to Beat Omicron, According to Some Nanotech Experts
January 19, 2022
From Benzinga
2 Top Healthcare Stocks Ready for a Bull Run
January 19, 2022
From Motley Fool
3 Under-the-Radar COVID Stocks
January 19, 2022
From Motley Fool
Could Novavax Go Parabolic?
January 19, 2022
From Motley Fool
Stocks still look attractive even with the Fed tightening
January 19, 2022
From MarketWatch
7 of the Top-Rated Pharmaceutical Stocks for Q1
January 18, 2022
From InvestorPlace
Why BioNTech, Moderna, and Novavax Stocks Are Sinking Today
January 18, 2022
From Motley Fool
Why Moderna, Pfizer, BioNTech And Novavax Shares Are Falling Today
January 18, 2022
From Benzinga
Omicron cases seem to have peaked in northeastern states, but national case tally is still at record levels and hospitals are slammed
January 18, 2022
From MarketWatch
Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
January 18, 2022
From Benzinga
Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition
January 18, 2022
From Benzinga
Brace for a volatile 2022, but cling to this tech stalwart when the storm comes, says investment advisor
January 18, 2022
From MarketWatch
Pfizer To Boost Output For COVID-19 Oral Treatment With Novasep Deal
January 18, 2022
Tickers
PFE
From Benzinga
FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis
January 18, 2022
From Benzinga
Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed
January 18, 2022
From Benzinga
4 Shots Of Pfizer COVID-19 Vaccine Not Enough To Prevent Omicron Infection, Say Israeli Researchers
January 18, 2022
From Benzinga
Preliminary Israeli study shows fourth COVID booster doesn’t stop omicron infections
January 18, 2022
From MarketWatch
7 Long-Term Stocks to Buy and Hold Until 2030
January 17, 2022
From InvestorPlace
Is Moderna Stock Too Expensive in 2022?
January 17, 2022
From Motley Fool
2 Top Biotech Stocks to Buy and Hold for 10 Years
January 17, 2022
From Motley Fool
3 Top Dividend Stocks on Robinhood's Most Popular List
January 17, 2022
From Motley Fool
From MarketWatch
3 Pharma Stocks With Especially Juicy Dividends
January 16, 2022
From Motley Fool
How Do Pfizer's and Merck's COVID Pills Work?
January 16, 2022
From Motley Fool
Is Beam Therapeutics a Good Stock to Buy Now?
January 16, 2022
From Motley Fool
3 Top Dividend Stocks to Buy Now
January 16, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.